Browse By: Country ι Category ι Publisher ι Tag
Home  »  Pharmaceutical

Pharmaceutical Market Research Reports

Pharmaceutical Market Research Reports & Industry Analysis at ResearchMoz
More

Restenosis Global Clinical Trials ReviewH22014
Restenosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Restenosis Global Clinical Trials Review, H2, 2014" provides data on the Restenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Restenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Restenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Sick Sinus Syndromes Global Clinical Trials ReviewH22014
Sick Sinus Syndromes Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Sick Sinus Syndromes Global Clinical Trials Review, H2, 2014" provides data on the Sick Sinus Syndromes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sick Sinus Syndromes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sick Sinus Syndromes. This report is built using data and information sourced from proprietary databases, prima
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Endothelial Dysfunction Global Clinical Trials ReviewH22014
Endothelial Dysfunction Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Endothelial Dysfunction Global Clinical Trials Review, H2, 2014" provides data on the Endothelial Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endothelial Dysfunction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Endothelial Dysfunction. This report is built using data and information sourced from proprietary d
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Giant Cell Arteritis Global Clinical Trials ReviewH22014
Giant Cell Arteritis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Giant Cell Arteritis Global Clinical Trials Review, H2, 2014" provides data on the Giant Cell Arteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Giant Cell Arteritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Giant Cell Arteritis. This report is built using data and information sourced from proprietary databases, prima
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Heart Attack Global Clinical Trials ReviewH22014
Heart Attack Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Heart Attack Global Clinical Trials Review, H2, 2014" provides data on the Heart Attack clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Attack. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Heart Attack. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house a
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Heart Valve Disease Global Clinical Trials ReviewH22014
Heart Valve Disease Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Heart Valve Disease Global Clinical Trials Review, H2, 2014" provides data on the Heart Valve Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Valve Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Heart Valve Disease. This report is built using data and information sourced from proprietary databases, primary an
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Hematoma Global Clinical Trials ReviewH22014
Hematoma Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hematoma Global Clinical Trials Review, H2, 2014" provides data on the Hematoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDat
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Hot Flashes Global Clinical Trials ReviewH22014
Hot Flashes Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hot Flashes Global Clinical Trials Review, H2, 2014" provides data on the Hot Flashes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hot Flashes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hot Flashes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analys
Published Date: Sep 2014
Published By: GlobalData

Price: $2500
Gastric Motility Disorder - Pipeline Review, H2 2014
Gastric Motility Disorder - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Gastric Motility Disorder - Pipeline Review, H2 2014, provides an overview of the Gastric Motility Disorders therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Gastric Motility Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastric Motility Disorder and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Iron Deficiency Anemia - Pipeline Review, H2 2014
Iron Deficiency Anemia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Iron Deficiency Anemia - Pipeline Review, H2 2014, provides an overview of the Iron Deficiency Anemias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Iron Deficiency Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014
Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014, provides an overview of the Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Chronic Cough - Pipeline Review, H2 2014
Chronic Cough - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Chronic Cough - Pipeline Review, H2 2014, provides an overview of the Chronic Coughs therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Cough, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Cough and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Dystonia - Pipeline Review, H2 2014
Dystonia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Dystonia - Pipeline Review, H2 2014, provides an overview of the Dystonias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Dystonia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dystonia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Lyme Disease - Pipeline Review, H2 2014
Lyme Disease - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Lyme Disease - Pipeline Review, H2 2014, provides an overview of the Lyme Diseases therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Lyme Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lyme Disease and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Streptococcus Pyogenes Infections - Pipeline Review, H2 2014
Streptococcus Pyogenes Infections - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Streptococcus Pyogenes Infections - Pipeline Review, H2 2014, provides an overview of the Streptococcus Pyogenes Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Streptococcus Pyogenes Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Streptococcus Pyogenes Infections and special features on late-stage and discontinued projects.Global Markets Directs report features inves
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Infections Caused By Picornaviridae - Pipeline Review, H2 2014
Infections Caused By Picornaviridae - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Infections Caused By Picornaviridae - Pipeline Review, H2 2014, provides an overview of the Infections Caused By Picornaviridaes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Infections Caused By Picornaviridae, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Infections Caused By Picornaviridae and special features on late-stage and discontinued projects.Global Markets Directs report feat
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Influenza A And B Infections - Pipeline Review, H2 2014
Influenza A And B Infections - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Influenza A And B Infections - Pipeline Review, H2 2014, provides an overview of the Influenza A And B Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Influenza A And B Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Influenza A And B Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acr
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Burkitt Lymphoma - Pipeline Review, H2 2014
Burkitt Lymphoma - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Burkitt Lymphoma - Pipeline Review, H2 2014, provides an overview of the Burkitt Lymphomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Burkitt Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Burkitt Lymphoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Uterine Cancer - Pipeline Review, H2 2014
Uterine Cancer - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Uterine Cancer - Pipeline Review, H2 2014, provides an overview of the Uterine Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Uterine Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Uterine Cancer and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Hypogonadotropic Hypogonadism - Pipeline Review, H2 2014
Hypogonadotropic Hypogonadism - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Hypogonadotropic Hypogonadism - Pipeline Review, H2 2014, provides an overview of the Hypogonadotropic Hypogonadisms therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hypogonadotropic Hypogonadism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hypogonadotropic Hypogonadism and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Muscle Atrophy - Pipeline Review, H2 2014
Muscle Atrophy - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Muscle Atrophy - Pipeline Review, H2 2014, provides an overview of the Muscle Atrophys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Muscle Atrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Muscle Atrophy and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $2000
Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2014
Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2014, provides an overview of the Inotek Pharmaceuticals Corporations pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Inotek Pharmaceuticals Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Lipella Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Lipella Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Lipella Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Lipella Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Lipella Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Ultragenyx Pharmaceutical Inc. - Product Pipeline Review - 2014
Ultragenyx Pharmaceutical Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Ultragenyx Pharmaceutical Inc. - Product Pipeline Review - 2014, provides an overview of the Ultragenyx Pharmaceutical Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Ultragenyx Pharmaceutical Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 2
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
VentiRx Pharmaceuticals, Inc. - Product Pipeline Review - 2014
VentiRx Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, VentiRx Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the VentiRx Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of VentiRx Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Alethia Biotherapeutics Inc. - Product Pipeline Review - 2014
Alethia Biotherapeutics Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Alethia Biotherapeutics Inc. - Product Pipeline Review - 2014, provides an overview of the Alethia Biotherapeutics Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Alethia Biotherapeutics Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therap
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Celsus Therapeutics Plc - Product Pipeline Review - 2014
Celsus Therapeutics Plc - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Celsus Therapeutics Plc - Product Pipeline Review - 2014, provides an overview of the Celsus Therapeutics Plcs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Celsus Therapeutics Plcs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
FAES Farma SA - Product Pipeline Review - 2014
FAES Farma SA - Product Pipeline Review - 2014SummaryGlobal Markets Directs, FAES Farma SA - Product Pipeline Review - 2014, provides an overview of the FAES Farma SAs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of FAES Farma SAs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built us
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Genextra S.p.a. - Product Pipeline Review - 2014
Genextra S.p.a. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Genextra S.p.a. - Product Pipeline Review - 2014, provides an overview of the Genextra S.p.a.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Genextra S.p.a.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Molecular Design International, Inc. - Product Pipeline Review - 2014
Molecular Design International, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Molecular Design International, Inc. - Product Pipeline Review - 2014, provides an overview of the Molecular Design International, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Molecular Design International, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acro
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2014
TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2014, provides an overview of the TaiGen Biotechnology Co., Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of TaiGen Biotechnology Co., Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 2
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Zosano, Inc. - Product Pipeline Review - 2014
Zosano, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Zosano, Inc. - Product Pipeline Review - 2014, provides an overview of the Zosano Pharma, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Zosano Pharma, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report i
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
ProteoTech, Inc. - Product Pipeline Review - 2014
ProteoTech, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, ProteoTech, Inc. - Product Pipeline Review - 2014, provides an overview of the ProteoTech, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of ProteoTech, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Clera Inc. - Product Pipeline Review - 2014
Clera Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Clera Inc. - Product Pipeline Review - 2014, provides an overview of the Clera Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Clera Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Errant Gene Therapeutics, LLC - Product Pipeline Review - 2014
Errant Gene Therapeutics, LLC - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Errant Gene Therapeutics, LLC - Product Pipeline Review - 2014, provides an overview of the Errant Gene Therapeutics, LLCs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Errant Gene Therapeutics, LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 th
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Esperance Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Esperance Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Esperance Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering ov
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
IMMD Inc. - Product Pipeline Review - 2014
IMMD Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, IMMD Inc. - Product Pipeline Review - 2014, provides an overview of the IMMD Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of IMMD Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inf
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
ObeTherapy Biotechnology - Product Pipeline Review - 2014
ObeTherapy Biotechnology - Product Pipeline Review - 2014SummaryGlobal Markets Directs, ObeTherapy Biotechnology - Product Pipeline Review - 2014, provides an overview of the ObeTherapy Biotechnologys pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of ObeTherapy Biotechnologys, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and near
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Phenex Pharmaceuticals AG - Product Pipeline Review - 2014
Phenex Pharmaceuticals AG - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Phenex Pharmaceuticals AG - Product Pipeline Review - 2014, provides an overview of the Phenex Pharmaceuticals AGs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Phenex Pharmaceuticals AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Recepta Biopharma S.A. - Product Pipeline Review - 2014
Recepta Biopharma S.A. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Recepta Biopharma S.A. - Product Pipeline Review - 2014, provides an overview of the Recepta Biopharma S.A.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Recepta Biopharma S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Physica Pharma - Product Pipeline Review - 2014
Physica Pharma - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Physica Pharma - Product Pipeline Review - 2014, provides an overview of the Physica Pharmas pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Physica Pharmas, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is buil
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Pherin Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Pherin Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Pherin Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Pherin Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Pherin Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therap
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
PsychoGenics, Inc. - Product Pipeline Review - 2014
PsychoGenics, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, PsychoGenics, Inc. - Product Pipeline Review - 2014, provides an overview of the PsychoGenics, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of PsychoGenics, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Th
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Q Chip Ltd. - Product Pipeline Review - 2014
Q Chip Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Q Chip Ltd. - Product Pipeline Review - 2014, provides an overview of the Q Chip Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Q Chip Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
OncoImmune, Inc. - Product Pipeline Review - 2014
OncoImmune, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, OncoImmune, Inc. - Product Pipeline Review - 2014, provides an overview of the OncoImmune, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of OncoImmune, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Jasco Pharmaceuticals, LLC. - Product Pipeline Review - 2014
Jasco Pharmaceuticals, LLC. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Jasco Pharmaceuticals, LLC. - Product Pipeline Review - 2014, provides an overview of the Jasco Pharmaceuticals, LLC.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Jasco Pharmaceuticals, LLC.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Arthrogen BV - Product Pipeline Review - 2014
Arthrogen BV - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Arthrogen BV - Product Pipeline Review - 2014, provides an overview of the Arthrogen BVs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Arthrogen BVs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Ascendis Pharma A/S - Product Pipeline Review - 2014
Ascendis Pharma A/S - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Ascendis Pharma A/S - Product Pipeline Review - 2014, provides an overview of the Ascendis Pharma A/Ss pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Ascendis Pharma A/Ss, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Bellicum Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Bellicum Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Bellicum Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Bellicum Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Bellicum Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 2
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
BerGenBio AS - Product Pipeline Review - 2014
BerGenBio AS - Product Pipeline Review - 2014SummaryGlobal Markets Directs, BerGenBio AS - Product Pipeline Review - 2014, provides an overview of the BerGenBio ASs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of BerGenBio ASs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Afferent Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Afferent Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Afferent Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Afferent Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Afferent Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 2
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Acumen Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Acumen Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therap
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Altacor Ltd. - Product Pipeline Review - 2014
Altacor Ltd. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Altacor Ltd. - Product Pipeline Review - 2014, provides an overview of the Altacor Ltd.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Altacor Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
ISA Pharmaceuticals B.V. - Product Pipeline Review - 2014
ISA Pharmaceuticals B.V. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, ISA Pharmaceuticals B.V. - Product Pipeline Review - 2014, provides an overview of the ISA Pharmaceuticals B.V.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of ISA Pharmaceuticals B.V.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and near
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Neurotech Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Neurotech Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Neurotech Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Neurotech Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Neurotech Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering ov
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Pique Therapeutics - Product Pipeline Review - 2014
Pique Therapeutics - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Pique Therapeutics - Product Pipeline Review - 2014, provides an overview of the Pique Therapeuticss pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Pique Therapeuticss, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Th
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Relmada Therapeutics, Inc. - Product Pipeline Review - 2014
Relmada Therapeutics, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Relmada Therapeutics, Inc. - Product Pipeline Review - 2014, provides an overview of the Relmada Therapeutics, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Relmada Therapeutics, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
Snowdon Inc. - Product Pipeline Review - 2014
Snowdon Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, Snowdon Inc. - Product Pipeline Review - 2014, provides an overview of the Snowdon Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Snowdon Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
sterna biologicals Gmbh & Co KG - Product Pipeline Review - 2014
sterna biologicals Gmbh & Co KG - Product Pipeline Review - 2014SummaryGlobal Markets Directs, sterna biologicals Gmbh & Co KG - Product Pipeline Review - 2014, provides an overview of the sterna biologicals Gmbh & Co KGs pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of sterna biologicals Gmbh & Co KGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering ov
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
TARIS BioMedical, Inc. - Product Pipeline Review - 2014
TARIS BioMedical, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, TARIS BioMedical, Inc. - Product Pipeline Review - 2014, provides an overview of the TARIS BioMedical, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of TARIS BioMedical, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
TAXIS Pharmaceuticals, Inc. - Product Pipeline Review - 2014
TAXIS Pharmaceuticals, Inc. - Product Pipeline Review - 2014SummaryGlobal Markets Directs, TAXIS Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the TAXIS Pharmaceuticals, Inc.s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of TAXIS Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy ar
Published Date: Sep 2014
Published By: Global Markets Direct

Price: $1500
CountryFocus: HealthcareRegulatory and Reimbursement Landscape - Venezuela
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - VenezuelaSummaryGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Venezuela. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Venezuela. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house an
Published Date: Sep 2014
Published By: GlobalData

Price: $1995
EpiCast Report: Asthma - Epidemiology Forecast to 2023
EpiCast Report: Asthma - Epidemiology Forecast to 2023SummaryAsthma is a chronic inflammatory lung disease that affects persons of all ages, but most commonly starts in childhood. It is a common long-term condition characterized by narrowing of the airways, leading to airflow limitation and airway hyper-responsiveness whenever the lungs come into contact with endogenous and exogenous irritants. Exposure to irritants instigates a series of events, such as swelling of the airways, tightening of the respiratory muscles, and increased mucus production, leading to reduced airflow into the lungs.In 2013, there were 137.66 million lifetime prevalent cases of asthma in the 10MM, with 82.71 million cases in the US (43.16 million cases) and India (39.55 million cases) combined. GlobalData epidemiolo
Published Date: Sep 2014
Published By: GlobalData

Price: $3995
EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023
EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023SummaryMacular edema (ME) occurs due to the thickening and swelling (edema) of the macula, which is the area of the retina that is responsible for central vision. In ME, fluid and protein deposits collect on or under the macula of the eye, due to a breakdown in the blood-retinal barrier. The occurrence of ME is highly frequent in diabetics and usually manifests itself as diabetic macular edema (DME). DME is often a complication of diabetic retinopathy, and is the most common cause of vision loss in individuals with diabetes, especially if left untreated. The risk for ME is high in patients with retinal vein occlusion (RVO), which consists of two types: branch retinal vein occlusion (BRVO) and central retinal vein occlusi
Published Date: Sep 2014
Published By: GlobalData

Price: $3995
EpiCast Report: Breast Cancer (HER2-HER2+) - Epidemiology Forecast to 2023
EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023SummaryBreast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body through the bloodstream and the lymphatic system. Prolonged exposure to endogenous and exogenous sex hormones, gene mutations, a family history of breast cancer, overweight and obesity, physical inactivity, a sedentary lifestyle, high alcohol consumption, early age at menarche (55 years), and clinical factors, such as biopsy-confirmed atypical hyperplasia, and having a high breast tissue and bone density are all risk factors for breast cancer.GlobalData epidemiologists forecast that the number
Published Date: Sep 2014
Published By: GlobalData

Price: $3995
EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2023
e-related macular degeneration (AMD) is a progressive eye condition caused by the gradual deterioration of the macula, which is the area of the retina responsible for central vision. AMD is the most common cause of significant irreversible vision loss among the elderly in the developed countries. In addition to the high prevalence of the condition, AMD is associated with severe disability and has a major impact on the quality of life and emotional well-being of an affected individual. AMD is classified into two stages: early AMD and late AMD. Late AMD is the advanced stage of AMD, which is further subclassified as dry AMD (geographic atrophy) and wet AMD (neovascular).GlobalData epidemiologists forecast that the total prevalent cases of AMD in the 7MM will increase from 55,770,401 cases in
Published Date: Sep 2014
Published By: GlobalData

Price: $3995
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The NetherlandsSummaryGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and
Published Date: Sep 2014
Published By: GlobalData

Price: $1995
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Hospital-acquired pneumonia also called as healthcare associated pneumonia or nosocomial pneumonia is acquired in hospital premises. Unlike community acquired pneumonia hospital acquired pneumonia is mainly caused due to multidrug resistant microorganisms. The report analyzes the market for late stage candidates for treatment of nosocomial pneumonia, and also provides a detailed review of drugs in early stages of clinical trials. The report studies and estimates market for six late stage along with an elucidation of ten early stage candidates for nosocomial pneumonia treatment. Phase III candidates include tedizolid phosphate, ceftolozane/tazobactam, ceftazidime/avibactam, amikacin inhale, plazomicin and synflorix vaccine. Market for each of the investigational drugs is estimated ba
Published Date: Sep 2014
Published By: Transparency Market Research

Price: $4795
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you ca
Published Date: Sep 2014
Published By: Current Partnering

Price: $3295
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you
Published Date: Sep 2014
Published By: Current Partnering

Price: $3295
CountryFocus: Healthcare Regulatory and Reimbursement Landscape - Australia
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - AustraliaSummaryGlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis
Published Date: Sep 2014
Published By: GlobalData

Price: $1995
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter preclinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   This report provides details of the latest preclinical agreements announced in the healthcare sector.   Understanding the flexibility of a prospective
Published Date: Sep 2014
Published By: Current Partnering

Price: $3295
Neutropenia - Pipeline Review, H2 2014
Global Markets Directs, Neutropenia Pipeline Review, H2 2014, provides an overview of the Neutropenias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Neutropenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neutropenia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014
Global Markets Directs, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Pipeline Review, H2 2014, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) and special features on late-stage and discontinue
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Atopic Dermatitis - Pipeline Review, H2 2014
Global Markets Directs, Atopic Dermatitis Pipeline Review, H2 2014, provides an overview of the Atopic Dermatitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atopic Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atopic Dermatitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Epilepsy - Pipeline Review, H2 2014
Global Markets Directs, Epilepsy Pipeline Review, H2 2014, provides an overview of the Epilepsys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epilepsy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Globa
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Cervical Cancer - Pipeline Review, H2 2014
Global Markets Directs, Cervical Cancer Pipeline Review, H2 2014, provides an overview of the Cervical Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cervical Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cervical Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data an
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Hemophilia B - Pipeline Review, H2 2014
Global Markets Directs, Hemophilia B Pipeline Review, H2 2014, provides an overview of the Hemophilia Bs therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hemophilia B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemophilia B and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Uveitis - Pipeline Review, H2 2014
Global Markets Directs, Uveitis Pipeline Review, H2 2014, provides an overview of the Uveitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Uveitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Globa
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Acute Coronary Syndrome - Pipeline Review, H2 2014
Global Markets Directs, Acute Coronary Syndrome Pipeline Review, H2 2014, provides an overview of the Acute Coronary Syndromes therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Coronary Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Coronary Syndrome and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. T
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Atrial Fibrillation - Pipeline Review, H2 2014
Global Markets Directs, Atrial Fibrillation Pipeline Review, H2 2014, provides an overview of the Atrial Fibrillations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atrial Fibrillation and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Renal Anemia - Pipeline Review, H2 2014
Global Markets Directs, Renal Anemia Pipeline Review, H2 2014, provides an overview of the Renal Anemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Renal Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Renal Anemia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Pertussis - Pipeline Review, H2 2014
Global Markets Directs, Pertussis Pipeline Review, H2 2014, provides an overview of the Pertussiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pertussis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced fr
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Diarrhea - Pipeline Review, H2 2014
Global Markets Directs, Diarrhea Pipeline Review, H2 2014, provides an overview of the Diarrheas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diarrhea and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from G
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Tetanus - Pipeline Review, H2 2014
Tetanus - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Tetanus - Pipeline Review, H2 2014, provides an overview of the Tetanuss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Tetanus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tetanus and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Urinary Tract Infections - Pipeline Review, H2 2014
Urinary Tract Infections - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Urinary Tract Infections - Pipeline Review, H2 2014, provides an overview of the Urinary Tract Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Urinary Tract Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Urinary Tract Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering o
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Growth Hormone Deficiency - Pipeline Review, H2 2014
Growth Hormone Deficiency - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Growth Hormone Deficiency - Pipeline Review, H2 2014, provides an overview of the Growth Hormone Deficiencys therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Growth Hormone Deficiency and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Dyskinesia - Pipeline Review, H2 2014
Dyskinesia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Dyskinesia - Pipeline Review, H2 2014, provides an overview of the Dyskinesias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Dyskinesia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dyskinesia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2014
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2014, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease) and specia
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Kidney Transplantation - Pipeline Review, H2 2014
Kidney Transplantation - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Kidney Transplantation - Pipeline Review, H2 2014, provides an overview of the Kidney Transplantations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Kidney Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Transplantation and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2014
Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2014, provides an overview of the Onychomycosis (Tinea Unguium)s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Onychomycosis (Tinea Unguium) and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs fro
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Oral Mucositis - Pipeline Review, H2 2014
Oral Mucositis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Oral Mucositis - Pipeline Review, H2 2014, provides an overview of the Oral Mucositiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Oral Mucositis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Oral Mucositis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Acute Ischemic Stroke - Pipeline Review, H2 2014
Acute Ischemic Stroke - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Acute Ischemic Stroke - Pipeline Review, H2 2014, provides an overview of the Acute Ischemic Strokes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Ischemic Stroke and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Thrombocytopenia - Pipeline Review, H2 2014
Thrombocytopenia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Thrombocytopenia - Pipeline Review, H2 2014, provides an overview of the Thrombocytopenias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thrombocytopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Thrombocytopenia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 in
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Erectile Dysfunction - Pipeline Review, H2 2014
Erectile Dysfunction - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Erectile Dysfunction - Pipeline Review, H2 2014, provides an overview of the Erectile Dysfunctions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Erectile Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Erectile Dysfunction and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Actinic (Solar) Keratosis - Pipeline Review, H2 2014
Actinic (Solar) Keratosis - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Actinic (Solar) Keratosis - Pipeline Review, H2 2014, provides an overview of the Actinic (Solar) Keratosiss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Actinic (Solar) Keratosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Actinic (Solar) Keratosis and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe cover
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2014
Acute Respiratory Distress Syndrome - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Acute Respiratory Distress Syndrome - Pipeline Review, H2 2014, provides an overview of the Acute Respiratory Distress Syndromes therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Respiratory Distress Syndrome and special features on late-stage and discontinued projects.Global Markets Directs report feat
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Opium (Opioid) Addiction - Pipeline Review, H2 2014
Opium (Opioid) Addiction - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Opium (Opioid) Addiction - Pipeline Review, H2 2014, provides an overview of the Opium (Opioid) Addictions therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Opium (Opioid) Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Opium (Opioid) Addiction and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering o
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Constipation - Pipeline Review, H2 2014
Constipation - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Constipation - Pipeline Review, H2 2014, provides an overview of the Constipations therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Constipation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Constipation and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The repor
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000
Postherpetic Neuralgia - Pipeline Review, H2 2014
Postherpetic Neuralgia - Pipeline Review, H2 2014SummaryGlobal Markets Directs, Postherpetic Neuralgia - Pipeline Review, H2 2014, provides an overview of the Postherpetic Neuralgias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Postherpetic Neuralgia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Postherpetic Neuralgia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 the
Published Date: Aug 2014
Published By: Global Markets Direct

Price: $2000